A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps
September 30, 2022
September 30, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Potomac Center for Medical Education and Rockpointe.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Physicians — 1.0 Medical Knowledge ABIM MOC points
- Physicians — maximum of 1.0 AAFP Enduring Materials, Self-Study Prescribed Credit
All other healthcare professionals completing this course will be issued a statement of participation.
- Welcome and Introduction
- Identifying the Source of the Problem
- Finding an Effective Treatment
- Q & A Session and Activity Roundup
The intended audience for this educational initiative includes primary care physicians, allergists and other clinicians who manage patients with chronic rhinosinusitis with nasal polyps.
This activity will review the major causes of nasal polyps and how to diagnose CRSwNP, the pathophysiology of CRSwNP, the safety and efficacy of approved treatment options that target the underlying pathophysiology of CRSwNP, and new agents on the horizon.
At the conclusion of this education, participants should be able to:
- Describe the role of the immune system in the pathogenesis of chronic rhinosinusitis with nasal polyps
- Diagnose patients with Th2-driven nasal polyps based on current guideline recommendations
- Evaluate current and emerging treatment options for patients with chronic rhinosinusitis with nasal polyps on the basis of safety and efficacy data
- Integrate novel biologic therapy into the management of patients with chronic rhinosinusitis with nasal polyps
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Family Medicine Residency Program
Abington Jefferson Health
Eileen Wang, MD
Division of Allergy and Immunology
Department of Medicine
National Jewish Health
University of Colorado School of Medicine
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation Statement
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Credit Designation Statement
The AAFP has reviewed A Breath of Fresh Air: New Treatment Strategies for Chronic Rhinosinusitis with Nasal Polyps and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 09/30/2022 to 09/30/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by PCME.
The faculty, authors, and content developers reported the following relevant financial relationships with ineligible companies:
- Neil Skolnik, MD
- Consulting Fee: Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Genentech, GSK, Idorsia, Lilly, Sanofi, Sanofi Pasteur, Teva
- Contracted Research: AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Novo Nordisk, Sanofi
- Speakers' Bureau: AstraZeneca, Bayer, Boheringer Ingelheim, GSK, Lilly
- Eileen Wang, MD
- Consulting Fee: AstraZeneca, GlaxoSmithKline, WeFight
- Contracted Research: AstraZeneca, Genentech, GlaxoSmithKline, Sanofi
- Honoraria: AstraZeneca
- Speakers’ Bureau: AstraZeneca
Brian W. Jack, MD, has no relevant financial relationships to disclose.
The planners and managers reported the following relevant financial relationships with ineligible companies:
Chelsey Goins, PhD, has no relevant financial relationships to disclose.
The content reviewers reported the following relevant financial relationships with ineligible companies:
Katie Propst, PhD, has no relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME/AAFP/MOC credit for this enduring activity. To receive CME credit participants must:
- Participate in this one-hour-long activity.
- Complete the online post-test and receive a score of ≥ 70%
- Complete the online evaluation.
Certificates will be emailed to the participant.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions please contact: firstname.lastname@example.org